RhumbLine Advisers’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.32M | Sell |
|
|||||
|
2025
Q2 | $1.92M | Sell |
|
|||||
|
2025
Q1 | $1.99M | Buy |
|
|||||
|
2024
Q4 | $1.84M | Buy |
|
|||||
|
2024
Q3 | $1.87M | Sell |
|
|||||
|
2024
Q2 | $1.48M | Buy |
|
|||||
|
2024
Q1 | $1.23M | Sell |
|
|||||
|
2023
Q4 | $1.29M | Buy |
|
|||||
|
2023
Q3 | $841K | Buy |
|
|||||
|
2023
Q2 | $616K | Buy |
|
|||||
|
2023
Q1 | $225K | Buy |
|
|||||
|
2022
Q4 | $319K | Buy |
|
|||||
|
2022
Q3 | $314K | Buy |
|
|||||
|
2022
Q2 | $467K | Buy |
|
|||||
|
2022
Q1 | $603K | Sell |
|
|||||
|
2021
Q4 | $758K | Buy |
|
|||||
|
2021
Q3 | $815K | Buy |
|
|||||
|
2021
Q2 | $766K | Sell |
|
|||||
|
2021
Q1 | $1.04M | Sell |
|
|||||
|
2020
Q4 | $736K | Buy |
|
|||||
|
2020
Q3 | $597K | Sell |
|
|||||
|
2020
Q2 | $844K | Buy |
|
|||||
|
2020
Q1 | $539K | Buy |
|
|||||
|
2019
Q4 | $709K | Buy |
|
|||||
|
2019
Q3 | $377K | Sell |
|
|||||
|
2019
Q2 | $938K | Buy |
|
|||||
|
2019
Q1 | $1.75M | Sell |
|
|||||
|
2018
Q4 | $1.7M | Buy |
|
|||||
|
2018
Q3 | $1.94M | Sell |
|
|||||
|
2018
Q2 | $1.53M | Buy |
|